Comparison of Once‐Daily Captopril or Enalapril in Mild Essential Hypertension
- 1 February 1989
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 29 (2) , 118-122
- https://doi.org/10.1002/j.1552-4604.1989.tb03298.x
Abstract
The purpose of this study was to assess the effect of a daily low dose of the angiotensin‐converting enzyme (ACE) inhibitors, captopril or enalapril, in mild essential hypertension. Nine men with seated diastolic blood pressure between 95 and 104 mm Hg on placebo participated in the study. After one month of placebo, captopril 25 mg was administered; blood pressure, heart rate, ACE activity and plasma renin activity were measured hourly for 4 hours. Each patient then received captopril 50 mg once daily for 8 weeks and similar measurements were made 24 hours post‐dose every 2 weeks. After another month of placebo, the identical protocol was repeated after enalapril 5 mg. Although blood pressure and ACE activity decreased significantly (P < 0.05) within 2–4 hours of the acute doses of each inhibitor, neither captopril or enalapril produced significant reductions 24 hours after the small daily dose. Thus, neither ACE inhibitor alone was adequate to control blood pressure in mild hypertension when given once daily during 8 weeks of treatment.This publication has 13 references indexed in Scilit:
- The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1988
- Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalaprilThe American Journal of Medicine, 1986
- Borderline mild systemic hypertension: Should it be treated?The American Journal of Cardiology, 1986
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Double-blind comparison of captopril and enalapril in mild to moderate hypertensionJournal of the American College of Cardiology, 1986
- MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.BMJ, 1985
- Pharmacokinetics of repeated single oral doses of enalapril maleate (mk‐421) in normal volunteersBiopharmaceutics & Drug Disposition, 1984
- Conflicting clinical trials and the uncertainty of treating mild hypertensionThe American Journal of Medicine, 1983
- Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.Hypertension, 1980
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977